Compile Data Set for Download or QSAR
maximum 50k data
Found 17 Enz. Inhib. hit(s) with all data for entry = 6289
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120768(US8703720, Reference Compound 1)
Affinity DataKd: >1.00E+7nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120776(US8703720, 23)
Affinity DataKd:  1.40E+3nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120771(US8703720, 15)
Affinity DataKd:  1.90E+3nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120772(US8703720, 16)
Affinity DataKd:  1.50E+3nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120773(US8703720, 17)
Affinity DataKd:  1.20E+3nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120774(US8703720, 18)
Affinity DataKd:  350nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120775(US8703720, 19)
Affinity DataKd:  1.30E+3nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120776(US8703720, 23)
Affinity DataKd:  6.30E+3nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120768(US8703720, Reference Compound 1)
Affinity DataKd:  4.40E+6nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120769(US8703720, Reference Compound 2)
Affinity DataKd:  5.90E+4nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120770(US8703720, 7)
Affinity DataKd:  430nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120771(US8703720, 15)
Affinity DataKd:  230nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120772(US8703720, 16)
Affinity DataKd:  150nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120773(US8703720, 17)
Affinity DataKd:  210nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120774(US8703720, 18)
Affinity DataKd:  550nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120775(US8703720, 19)
Affinity DataKd:  190nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM120769(US8703720, Reference Compound 2)
Affinity DataKd:  6.50E+4nMAssay Description:Compounds 7, 15-19, and 22 were evaluated for their efficiency in inhibiting galectin-1 and galectin-3 in a known fluorescence polarization-based ass...More data for this Ligand-Target Pair
In DepthDetails US Patent